Three notes:
1. Medisource Partners supplies and distributes bone grafts and biologics from a range of companies.
2. Per the agreement, Generex will acquire all of Medisource Partners’ assets, including business operations, accounts receivable and inventory, contracts and real estate.
3. The biotechnology company will acquire Medisource Partners for $1 million worth of its stock, in addition to cash and stock considerations for achieving certain sales and projections.
More articles on biologics:
SpinalCyte earns international patent for biologic product: 3 insights
DiscGenics’ cell therapy passes safety review of first-in-human trial: 5 things to know
3 things to know about JRF Ortho
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
